Lingxi Jiang

机构：Shanghai Jiao Tong University, Ruijin Hospital, Shanghai Cancer Institute · ORCID：0000-0002-8070-5275

发表论文 40 篇 · 总被引 1056 次 · h-index 16

代表论文

• Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment (2023 · Nature Communications · 被引 142)
• RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2 (2021 · Nature Communications · 被引 85)
• ANGPTL1 Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling (2017 · Cancer Research · 被引 73)
• Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma (2024 · Nature Medicine · 被引 58)
• Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors (2024 · Cell Research · 被引 43)
• Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for Pancreatic Ductal Adenocarcinoma (2020 · Research Square · 被引 42)